Quarry LP’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,132
Closed -$230K 2463
2026
Q1
$230K Buy
+14,132
New +$236K 0.04% 307
2025
Q2
Sell
-71,459
Closed -$907K 1860
2025
Q1
$907K Sell
71,459
-73,663
-51% -$998K 0.2% 89
2024
Q4
$1.9M Sell
145,122
-40,392
-22% -$583K 0.27% 57
2024
Q3
$2.8M Sell
185,514
-20,190
-10% -$306K 0.7% 31
2024
Q2
$2.91M Sell
205,704
-19,081
-8% -$258K 0.84% 21
2024
Q1
$3.06M Buy
224,785
+154,075
+218% +$2.13M 0.59% 36
2023
Q4
$952K Buy
70,710
+8,460
+14% +$104K 0.15% 94
2023
Q3
$776K Buy
+62,250
New +$819K 0.18% 91

Other funds holding HQL

Quarry LP's HQL Position: Q2 2026 in Review

Quarry LP sold out of abrdn Life Sciences Investors (HQL) in Q2 2026, closing a stake of 14,132 shares — an estimated $230K sold.

Quarry LP first reported a position in HQL in Q3 2023 and held it in 8 quarters. The position peaked at $3.06M in Q1 2024. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Quarry LP reported no remaining abrdn Life Sciences Investors position as of Q2 2026 after selling out during the quarter.
  • Quarry LP sold 14,132 abrdn Life Sciences Investors shares in Q2 2026, an estimated $230K.
  • Quarry LP first reported a position in abrdn Life Sciences Investors in Q3 2023 and held it in 8 quarters.
  • Quarry LP's abrdn Life Sciences Investors position peaked at $3.06M in Q1 2024.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.